We have established an immunoassay for pre  1-HDL (the initial acceptor of cellular cholesterol) using a monoclonal antibody, MAb55201. Because pre  1-HDL is unstable during storage, fresh plasma must be used for pre  1-HDL measurements. In this study, we describe a method of stabilizing pre  1-HDL, and evaluate the analytical performance of the immunoassay for pre  1-HDL. Fresh plasma was stored under various conditions with or without a pretreatment consisting of a 21-fold dilution into 50% (v/v) sucrose. Pre  1-HDL concentration was measured by immunoassay. In nonpretreated samples, pre  1-HDL decreased significantly from the baseline after 6 h at room temperature. Although pre  1-HDL was more stable at 0 ؇ C than at room temperature, it increased from 30.2 ؎ 8.5 (SE) to 56.5 ؎ 5.5 mg/l apolipoprotein A-I (apoA-I) ( P Ͻ 0.001) in hyperlipidemics, and from 18.4 ؎ 1.2 to 37.9 ؎ 3.3 mg/l apoA-I ( P Ͻ 0.001) in normolipidemics after 5-day storage. After 30-day storage at ؊ 80 ؇ C, pre  1-HDL increased from 29.0 ؎ 4.0 to 38.0 ؎ 5.7 mg/l apoA-I ( P Ͻ 0.001) in hyperlipidemics, whereas it did not change in normolipidemics. In pretreated samples, pre  1-HDL concentration did not change significantly under any of the above conditions. Moreover, pre  1-HDL concentrations determined by immunoassay correlated with those determined by native two-dimensional gel electrophoresis (n ؍ 24, r ؍ 0.833, P Ͻ 0.05).An immunoassay using MAb55201 with pretreated plasma is useful for clinical measurement of pre  1-HDL.